Navigation Links
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Date:4/15/2013

SAN DIEGO, April 15, 2013 /PRNewswire/ -- Ambit Biosciences Corporation today announced that David R. Parkinson , M.D., has been appointed to the company's board of directors. Dr. Parkinson is a venture partner at New Enterprise Associates, a position he has held since 2012, and a member of the board of directors for Threshold Pharmaceuticals, a publicly-traded oncology company, and Zyngenia, Inc. He served as a director of Facet Biotech through its acquisition by Abbott in 2010. 

Prior to joining New Enterprise Associates, Dr. Parkinson was president and chief executive officer of Nodality, a biotechnology company focused on personalized medicine. Before this, he held positions as senior vice president of oncology research at Biogen Idec, vice president of oncology development at Amgen, Inc, and vice president of global clinical oncology development at Novartis Corporation. Dr. Parkinson previously held multiple positions with the National Cancer Institute from 1990 to 1997, including chief of the Investigational Drug Branch and associate director of the Cancer Therapy Evaluation Program. He has also served on the National Cancer Policy Forum of the Institute of Medicine and is a past president of the International Society of Biological Therapy. He is a past Chairman of the FDA's Biologics Advisory Committee and member of the FDA Science Board, and is a recipient of the FDA's Cody Medal .  Dr. Parkinson received his medical doctorate from the University of Toronto Faculty of Medicine, with internal medicine and hematology/oncology training at McGill University in Montreal and at New England Medical Center in Boston. He has held academic positions at the M.D. Anderson Cancer Center, University of Texas and New England Medical Center at Tufts University School of Medicine.

"David brings to Ambi
'/>"/>

SOURCE Ambit Biosciences Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
2. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
3. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
4. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
5. Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
6. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
7. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
8. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
9. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
10. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
11. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3,  2015 About artificial ... devices, which are implanted or integrated into ... These include artificial heart, kidney, pancreas, and ... (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, ... organs. These organs are incorporated with different ...
(Date:9/3/2015)... , Sept. 3, 2015  WellCare Health Plans, Inc. ... Asher , senior vice president and chief financial officer, ... 2015 Healthcare Conference on Wednesday, September 9, 2015, at ... be webcast live. In addition, a replay of the ... live broadcast. Both the live broadcast and the replay ...
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Investigation Report on China,s ... The clinical demand for steroid drug ... and good efficacy especially its extended use in ... recent years. Progesterone, a natural progestogen produced ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2China Progesterone Market Investigation Report 2015-2019 2
... 26, 2012 Los Angeles Lakers, power forward Pau ... care company with U.S. headquarters in Los Angeles, to ... Hospital Los Angeles. The new Phocus Rx ... of pediatric medications. "It,s a win-win-win for Children,s Hospital ...
...  Republican presidential candidate Mitt Romney advocated the creation of specialized ... USA Today . In the op-ed, Romney stated: ... litigation, which is costly not only in direct terms, but ... administered. We can start by capping non-economic damages, but the ...
Cached Medicine Technology:LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles 2LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles 3Health Courts Continue to Gain Bipartisan Support From 2012 Presidential Candidates 2Health Courts Continue to Gain Bipartisan Support From 2012 Presidential Candidates 3
(Date:9/3/2015)... ... ... AlignLife of Wauwatosa is excited to hold its annual Coat ... adults who don't have the ability to buy a jacket warm enough for the ... Drive to help those in need." , This is AlignLife's third annual Coat Drive. ...
(Date:9/3/2015)... ... ... William Mattar Law Offices is known for its slogan “Helping People, It’s ... certain demographic or segment of the population. Because of this, the firm will ... , The closed captioning will allow people with hearing impairments or who are deaf ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... he made the company the final destination of his six-month, 10,000 mile journey ... , During the trek—which he calls the “Connecting Las Americas” project—Max crossed ...
(Date:9/3/2015)... BELLINGHAM, WA (PRWEB) , ... September 03, 2015 ... ... new memory care community to be situated at 4400 Columbine Drive in Bellingham, ... in late 2016, and has been carefully designed to serve up to 80 ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... real estate investment landscape by connecting accredited and institutional investors to real estate ... products designed to meet demand from both investors and sponsoring real estate ...
Breaking Medicine News(10 mins):Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... medical experts frustrated , , TUESDAY, Sept. 11 (HealthDay News) ... 11, 2001, World Trade Center disaster on rescue and ... inhaled a toxic cocktail of soot, metals and other ... lasted for weeks. There was also the psychological toll ...
... Inc.,the nation,s leading independent advocacy and assistance company, announced,that it ... the nation,s,fastest growing private companies. In this year,s Inc. ... overall -- Placed in Top 2.5 percent of the ... evaluation period -- Ranked No. 9 in the Top ...
... Sept. 11 DURECT,Corporation (Nasdaq: DRRX ) ... present at the 4th annual Merriman Curhan Ford ... 11:45 a.m. Pacific Time. This event will be,held ... Francisco. More,information about the conference can be found ...
... WASHINGTON, N.Y., Sept. 10 National,Medical Health Card Systems, ... manager ("PBM"), today reported its results for the fiscal,fourth ... Three months ended June 30, 2007 Revenue for ... to revenue of $211.5 million for the same period ...
... Inter-Arabe Is a Leader in Supporting Women,s Emancipation Through ... ... microfinance,to provide better economic opportunities for low-income entrepreneurs is,emerging in the ... to be represented in the WWB network. In all, WWB,s three ...
... Vitamins, Try Acupuncture, NORTHBROOK, Ill., Sept. 10 ... Chest Physicians (ACCP) recommend,against the use of low-dose ... cancer. Published as a supplement to the September ... the guidelines cite there,is little evidence to show ...
Cached Medicine News:Health News:6 Years Later, 9/11 Health Questions Linger 2Health News:6 Years Later, 9/11 Health Questions Linger 3Health News:6 Years Later, 9/11 Health Questions Linger 4Health News:6 Years Later, 9/11 Health Questions Linger 5Health News:Health Advocate Recognized by Inc. 500 as One of the Nation's Fastest Growing Private Companies 2Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 5Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 6Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 7Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 8Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 9Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 10Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 11Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 12Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 13Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 14Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 15Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 16Health News:Women's World Banking Welcomes New Network Member From Tunisia 2Health News:Women's World Banking Welcomes New Network Member From Tunisia 3Health News:Women's World Banking Welcomes New Network Member From Tunisia 4Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
Medicine Products: